NCT06216522

Brief Summary

The goal of this randomised controlled trial is to determine the effectiveness of topical sesame oil in preventing phlebitis at peripheral intravenous (IV) cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital. The main question it aims to answer is: Is topical sesame oil effective in preventing phlebitis at peripheral IV cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital? Participants will be randomly allocated to the experimental or control group with the use of a randomisation software (MS excel). They will each have five drops/0.25mls of 100% sesame oil (experimental) or liquid paraffin oil (control) applied to the IV cannula site, at 12 hourly intervals for a total of 72 hours, from 3cm above the insertion point to 10cm along the vein, with a width of 2cm on either side. Researchers will compare the phlebitis incidence and severity of each group to see if topical sesame oil is more effective than liquid paraffin oil in preventing phlebitis at IV cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
263

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

6 months

First QC Date

January 11, 2024

Last Update Submit

February 19, 2024

Conditions

Keywords

intravenous cannulaIV cannulaAdultCardiovascularCardiothoracicPhlebitisThrombophlebitis

Outcome Measures

Primary Outcomes (1)

  • Phlebitis incidence

    Measuring the incidence of phlebitis across both the intervention and control groups

    At 12 hourly intervals for a total of 72 hours

Secondary Outcomes (1)

  • Phlebitis severity

    At 12 hourly intervals for a total of 72 hours

Study Arms (2)

Intervention

EXPERIMENTAL

5 drops/0.25mls of 100% sesame oil will be applied to the IV cannula site, from 3cm above the insertion point to 10cm along the vein, with a width of 2cm on either side, every 12 hours for 72 hours.

Other: Topical Sesame Oil

Control

PLACEBO COMPARATOR

5 drops/0.25mls of liquid paraffin oil will be applied to the IV cannula site, from 3cm above the insertion point to 10cm along the vein, with a width of 2cm on either side, every 12 hours for 72 hours.

Other: Liquid paraffin oil

Interventions

5 drops/0.25mls of sesame oil applied to the IV cannula site at 12 hourly intervals for 72 hours

Intervention

5 drops/0.25mls of liquid paraffin oil applied to the IV cannula site at 12 hourly intervals for 72 hours

Control

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21-80
  • Patients must speak and understand either English or Mandarin
  • Patients who possess a peripheral IV cannula
  • IV cannula must have been inserted for less than 12 hours
  • IV cannula must be on an upper extremity
  • IV cannula must be patent
  • IV cannula sites must show no signs of redness, swelling, pain, a palpable venous cord or pyrexia
  • Patient must be admitted to a cardiology ward in the National Heart Centre Singapore

You may not qualify if:

  • Patients who do not speak or understand either English or Mandarin
  • Patients with venous insufficiency
  • Patients with coagulopathies
  • Patients with cognitive or sensory impairments that would inhibit their ability to rate their pain via a Numerical Rating Scale (NRS)
  • Patients who are receiving medications that might interfere with timely reporting of adverse events (eg. medications that cause severe drowsiness)
  • Patients who report allergies to sesame or liquid paraffin oil
  • IV cannulas that were inserted and used for resuscitation
  • Patients with existing skin conditions that cause their skin to be red or swollen and might affect the investigators ability to assess for phlebitis
  • Patients who possess more than one peripheral IV cannula will only be included in the study once. All subsequent IV cannula insertions will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Heart Centre Singapore

Singapore, 169609, Singapore

Location

Related Publications (1)

  • Jackson A. Infection control--a battle in vein: infusion phlebitis. Nurs Times. 1998 Jan 28-Feb 3;94(4):68, 71. No abstract available.

    PMID: 9510815BACKGROUND

MeSH Terms

Conditions

PhlebitisThrombophlebitis

Interventions

Sesame OilMineral Oil

Condition Hierarchy (Ancestors)

Peripheral Vascular DiseasesVascular DiseasesCardiovascular DiseasesVasculitisVenous ThrombosisThrombosisEmbolism and Thrombosis

Intervention Hierarchy (Ancestors)

Dietary Fats, UnsaturatedDietary FatsFatsLipidsFats, UnsaturatedPlant OilsOilsPlant PreparationsBiological ProductsComplex MixturesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesPetrolatumHydrocarbonsOrganic Chemicals

Study Officials

  • Jasmine Tan

    Nanyang Polytechnic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2024

First Posted

January 22, 2024

Study Start

April 12, 2022

Primary Completion

October 21, 2022

Study Completion

October 21, 2022

Last Updated

February 21, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations